In the case of endometrial and ovarian cancers, these mutations might either hamper the nuclear import of ARID1A, or affect the ability of ARID1A to interact with the subunits of SWI/SNF complex (Guan et al., 2012). Here, ARID1A is linked to ovarian cancer.